Antimalarial and cytotoxic activities of roots and fruits fractions of Astrodaucus persicus extract

Document Type: Original Article

Authors

1 Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

4 Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Objective(s):Astrodaucus persicus (Apiaceae) is one of the two species of this genus which grows in different parts of Iran. Roots of this plant were rich in benzodioxoles and used as food additive or salad in Iran and near countries. The aim of present study was evaluation of antimalarial and cytotoxic effects of different fractions of A. persicus fruits and roots extracts.
Materials and Methods: Ripe fruits and roots of A. persicuswere extracted and fractionated by hexane, chloroform, ethyl acetate and methanol, separately. Antimalarial activities of fractions were performed based on Plasmodium berghei suppressive test in mice model and percentage of parasitemia and suppression were determined for each sample. Cytotoxicity of fruits and roots fractions were investigated against human breast adenocarcinoma (MCF-7), colorectal carcinoma (SW480) and normal (L929) cell lines by MTT assay and IC50 of them were measured.
Results: Hexane fraction of roots extract (RHE) and ethyl acetate fraction of fruits extract (FEA) of A. persicus demonstrated highest parasite inhibition (73.3 and 72.3%, respectively at 500 mg/kg/day) which were significantly different from negative control group (P<0.05). In addition, RHE showed potent anticancer activities against MCF-7 (IC50 of 0.01 µg/ml), SW480 (IC50 of 0.36 µg/ml) and L929 (IC50 of 0.70 µg/ml) cell lines.
Conclusion: According to the results, RHE and FEA fractions of A. persicus could be introduced as excellent choice for antimalarial drug discovery. In addition, cytotoxic activity of RHE was noticeable.

Keywords


1. World Health Organization (WHO). World Malaria Report 2016. Switzerland: 2017.

2. Mengiste B, Makonnen E, Urga K. In vivo antimalarial activity of Dodonaea angustifolia seed extracts against Plasmodium berghei in mice model. Momona Ethiop J Sci 2012; 4:47-63.

3. Khodadadi M, Nateghpour M, Souri E, Farivar L, Motevalli Haghi A, et al. Evaluation of effectiveness of ethanolic extract of Artemisia aucheri, individually and in combination with chloroquine, on chloroquine - sensitive strain of Plasmodium berghei in sourian mice. Iranian J Pub Health 2013; 42: 883-888.

4. Muluye AB, Melese E, Adinew GM. Antimalarial activity of 80% methanolic extract of Brassica nigra (L.) Koch. (Brassicaceae) seeds against Plasmodium berghei infection in mice. BMC Complement Altern Med 2015; 15:367-375.

5. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008; 9:725-732.

6. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012; 75:311-335.

7. Onguene PA, Ntie-Kang F, Lifongo LL, Ndom JC, Sippl W, Mbaze LM. The potential of antimalarial compounds derived from African medicinal plants. Part I: A pharmacological evaluation of alkaloids and terpenoids. Malar J 2013; 12:449-474.

8. Pandey A, Tripathi S. Concept of standardization, extraction and pre-phytochemical screening strategies for herbal drug. J Pharmacogn Phytochem 2014; 2:115-119.

9. Schmidt TJ, Khalid SA, Romanha AJ, Alves TMA, Biavatti MW, Brun R, et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases-part I. Curr Med Chem 2012; 19:2128-2175.

10. Schmidt TJ, Khalid SA, Romanha AJ, Alves TMA, Biavatti MW, Brun R, et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases-part II. Curr Med Chem 2012; 19:2176-2228.

11. Nazemiyeh H, Razavi SM, Delazar A, Asnaashari S, Khoi NS, Daniali S, et al. Distribution profile of volatile constituents in different parts of Astrodaucus orientalis (L.) Drude. Rec Nat Prod 2009; 3:126-130.

12. Goodarzi S, Hadjiakhoondi A, Yassa N, Khanavi M, Tofighi Z. Essential oils chemical composition, antioxidant activities and total phenols of Astrodaucus persicus. Iran J Basic Med Sci 2016; 19:159-165.

13. Goodarzi S, Hadjiakhoondi A, Yassa N, Khanavi M, Tofighi Z.  New benzodioxole compounds from the root extract of Astrodaucus persicus Iran J Pharm Res 2016; 15: 901-906.

14. Gupta SD, Rao GB, Bommaka MK, Raghavendra NM, Aleti S. Eco-sustainable synthesis and biological evaluationof 2-phenyl 1,3-benzodioxole derivatives as anticancer, DNA binding and antibacterial agents. Arab J Chem 2016; 9:S1875-1883.

15. Nateghpour M, Farivar L, Souri E, Hajjaran H, Mohebali M, Motevalli Haghi A. The effect of Otostegia persica in combination with chloroquine on chloroquine-sensitive and chloroquine-resistant strains of Plasmodium berghei using         in-vivo fixed ratios method. Iran J Pharm Res 2012; 11:583-588.

16. Peters W. Chemotherapy and drug resistance in malaria. London: Academic Press; 1970. P.876.

17. Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov 2004; 3:509-520.

18. Kalra BS, Chawla S, Gupta P, Valecha N. Screening of antimalarial drugs: An overview. Indian J Pharmacol 2006; 38:5-12.

19. Tofighi Z, Asgharian P, Goodarzi S, Hadjiakhoondi A, Ostad SN, Yassa N. Potent cytotoxic flavonoids from Iranian Securigera securidaca. Med Chem Res 2014; 23:1718-1724.

20. Pena-Moran OA,Villarreal ML, Alvarez-Berber L, Meneses-Acosta A, Rodriguez-Lopez V. Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines. Molecules 2016; 21: 1013-1028.

21. Krettli AU, Adebayo JO, Krettli LG. Testing of natural products and synthetic molecules aiming at new antimalarials. Curr Drug Targets 2009; 10:261-270.

22. Adugna M, Feyera T, Taddese W, Admasu P. In vivo antimalarial activity of crude extract of aerial part of Artemisia abyssinica against Plasmodium berghei in mice. Global J Pharmacol 2014; 8:460-468.

23. Deharo E, Bourdy G, Quenevo C, Munoz V, Ruiz G, Sauvain M. A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part V. Evaluation of the antimalarial activity of plants used by the Tacana Indians. J Ethnopharmacol 2001; 77:91-98.

24. Rasoanaivo P, Wright CW, Willcox ML, Gilbert B. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malar J 2011; 10:4-15.

25. Builders MI, Uguru MO, Aguiyi C. Antiplasmodial potential of the African mistletoe: Agelanthus dodoneifolius Polh & Wiens. Indian J Pharm Sci 2012; 74:223-229.

26. Al-Adhroey AH, Nor ZM, Al-Mekhlafi HM, Mahmud R. Median lethal dose, antimalarial activity, phytochemical screening and radical scavenging of methanolic languas galangal rhizome extract. Molecules 2010; 15:8366-8376.

27. Ajaiyeoba E, Falade M, Ogbole O, Okpako L, Akinboye D. In vivo antimalarial and cytotoxic properties of Annona senegalensis extract. Afr J Trad CAM 2006; 3:137-141.

28. Abdolmohammadi MH, Fouladdel Sh, Shafiee A, Amin Gh, Ghaffari SM, Azizi E. Anticancer effects and cell cycle analysis on human breast cancer T47D cells treated with extracts of Astrodaucus persicus (Boiss.) Drude in comparison to doxorubicin. DARU 2008; 16:112-118.

29. Azizi E, Abdolmohammadi MH, Fouladdel Sh, Shafiee A, Amin Gh, Ghaffari SM. Evaluation of p53 and Bcl-2 genes and proteins expression in human breast cancer T47D cells treated with extracts of Astrodaucus persicus (Boiss.) Drude in comparison to tamoxifen, immunocytochemistry. DARU 2009; 17:181-186.

30. Sullivan JDJ, Kaludov N, Martinov MN. Discovery of potent, novel, non-toxic antimalarial compounds via quantum modelling, virtual screening and in vitro experimental validation. Malar J 2011; 10:274-182.

31. Fu YH, Li SL, Li SF, He HP, Di YT, Zhang Y, Hao XJ. Cytotoxic eburnamine-aspidospermine type bisindole alkaloids from Bousigonia mekongensis. Fitoterapia 2014; 98:45-52.

32. Cedron JC, Gutierrez D, Flores N, Ravelo AG, Estevez-Braun A. Synthesis and antiplasmodial activity of lycorine derivatives. Bioorganic Med Chem 2010; 18:4694-4701.

33. Miller EC, Swanson AB, Phillips DH, Fletcher TL, Liem A, Miller JA. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res 1983; 43:1124-1134.

34. Leite ACL, Silva KP, Souza IA, Araujo JM, Brondani DJ. Synthesis, antitumor and antimicrobial activities of new peptidyl derivatives containing the 1,3-benzodioxole system. Eur J Med Chem 2004; 39:1059-1065.

35. Hsiu-Man L, Po-Tsun K, Chao-Lu H, Jung-Yie K, Ho L, Ding-Yah Y, et al. Study of the anti-proliferative activity of 5-substituted 4,7-dimethoxy-1,3-benzodioxole derivatives of SY-1 from Antrodia camphorata on human COLO 205 colon cancer cells. J Evid Based Complement Altern Med 2011; 1-8.

36. Capilla AS, Sanchez I, Caignard DH, Renard P, Pujol MD. Antitumor agents, Synthesis and biological evaluation of new compounds related to podophyllotoxin, containing the 2, 3-dihydro-1,4-benzodioxin system. Eur J Med Chem 2001;36:389-393.

37. Chen GL, Yang L, Rowe TC, Halligan BD, Tewey K, Liu L. Non intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem1984; 259:13560-13566.

38. Hai-Hong W, Ke-Ming Q, Hong-En C, Yu-Shun Y, Yin L, Man X, et al. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents. Bioorg Med Chem Lett 2013; 21:448-455